Koumaki, Dimitra and Boumpoucheropoulos, Sotirios and Koumaki, Vasiliki and Katoulis, Alexander and Pappas, Georgia and Mantaka, Aikaterini and Krasagakis, Konstantinos (2020) Panitumumab-Induced Eruptive Seborrhoeic Keratosis in a Patient with Metastatic Colorectal Cancer. European Journal of Case Reports in Internal Medicine, 7 (2). ISSN 2284-2594
|
Text
1411-Article Text-11037-1-10-20200109.pdf - Published Version Download (860kB) | Preview |
Abstract
Objectives: Agents targeting the epidermal growth factor receptor (EGFR)-mediated signalling pathway are increasingly being used for the treatment of advanced lung, pancreatic, colorectal and head and neck cancers. Case presentation: Here, we report the first case of eruptive seborrhoeic keratosis following panitumumab treatment, an anti-EGFR monoclonal antibody, in a 73-year-old patient with stage 4 (IV) colorectal cancer with hepatic metastasis. Conclusion: While panitumumab is an emerging therapy for RAS wild-type metastatic colorectal cancer, physicians should consider panitumumab as a potential cause of eruptive seborrhoeic keratosis.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Panitumumab, eruptive seborrhoeic keratosis, drug-induced eruption |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Chiara D'Arpa |
| Date Deposited: | 19 Nov 2020 09:55 |
| Last Modified: | 19 Nov 2020 09:55 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/19806 |
Actions (login required)
 |
View Item |
